Vimarsana
Biggest News Aggregation in the World

Aexpres News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aexpres. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aexpres Today - Breaking & Trending Today

⚡ Noctis Labyrinthus: The Image of an Astonishing Maze on Mars - Vimarsana News

⚡ Noctis Labyrinthus: The Image of an Astonishing Maze on Mars

Mars continues to fascinate us. The European Space Agency (ESA) recently released a striking image of Noctis Labyrinthus, an extensive network of canyons located between the...

Uber India to add 25,000 Tata Xpres-T EVs to its fleet - Vimarsana News

Uber India to add 25,000 Tata Xpres-T EVs to its fleet

Tata Motors has signed a memorandum of understanding (MoU) with Uber India to deliver 25,000 Xpres-T electric cars. These will be inducted into Uber’s premium category service. Uber India is in

Tata Motors inks MoU with Uber for XPRES-T EVs - Vimarsana News

Tata Motors inks MoU with Uber for XPRES-T EVs

Uniindia: Hyderabad, Feb 20 (UNI) Tata Motors, India’s leading automobile manufacturer and the pioneer of India’s EV evolution, on Monday announced it has signed an Memorandum of Undestanding (MoU) with Uber, India’s leading ridesharing app, to bring 25,000 XPRES–T EVs into their premium category service.

Ultra-precise readings shed new light on a 'hell planet' with an 18-hour year - Vimarsana News

Ultra-precise readings shed new light on a 'hell planet' with an 18-hour year

Planet 55 Cnc e, also known as "Janssen", orbits so close to its sun that a year is shorter than an Earth day.

Evaxion Biotech: Evaxion and ExpreS²ion initiate research collaboration on a novel cytomegalovirus (CMV) vaccine candidate - Vimarsana News

Evaxion Biotech: Evaxion and ExpreS²ion initiate research collaboration on a novel cytomegalovirus (CMV) vaccine candidate

HØRSHOLM, Denmark, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) ("Evaxion" or the "Company"), a clinical-stage biotechnology company specializing in the development of AI-driven